Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nautilus Biotechnology, Inc. | 160,000 | reported | 02 Mar 2026 | tx 11+1,151,526 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 04 Sept 2025 | PURCHASE | Nautilus Biotechnology, Inc. | 20,000 | 0.64 USD | first after silence |
| 03 Mar 2025 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 27 Feb 2023 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 12 Aug 2022 | PURCHASE | Nautilus Biotechnology, Inc. | 2,500 | 2.85 USD | |
| 15 Aug 2022 | PURCHASE | Nautilus Biotechnology, Inc. | 7,500 | 2.84 USD | |
| 12 May 2022 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 10,000 | 3.28 USD | |
| 25 Feb 2022 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 140,000 | 0.00 USD | deriv |
| 13 Aug 2021 | PURCHASE | Nautilus Biotechnology, Inc. | 5,000 | 7.56 USD | |
| 14 Jun 2021 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 326,526 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 04 Sept 2025.